M Jinnin Selected Research

M Jinnin Research Topics

Disease

9	Systemic Scleroderma (Systemic Sclerosis) 06/2012 - 02/2003
5	Mixed Connective Tissue Disease (MCTD) 07/2005 - 07/2002
3	Dermatomyositis (Dermatopolymyositis) 05/2016 - 11/2002
3	Fibrosis (Cirrhosis) 11/2014 - 03/2006
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2006 - 10/2003
2	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2013
2	Neoplasms (Cancer) 01/2019 - 08/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2016 - 01/2012
2	Melanoma (Melanoma, Malignant) 12/2013 - 03/2013
2	Cicatrix (Scar) 10/2009 - 10/2004
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 05/2007 - 06/2005
2	Localized Scleroderma (Morphea) 07/2006 - 07/2005
2	Eosinophilic Fasciitis 08/2004 - 02/2003
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2019
1	Disease Progression 01/2019
1	Hemangioma (Angioma) 08/2017
1	Hemangiosarcoma (Angiosarcoma) 08/2017
1	Skin Diseases (Skin Disease) 05/2016
1	Inflammation (Inflammations) 12/2013
1	Carcinoma (Carcinomatosis) 03/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Ulcerative Colitis 01/2013
1	Lymphoma (Lymphomas) 03/2012
1	Atopic Dermatitis (Atopic Eczema) 11/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2011
1	Breast Neoplasms (Breast Cancer) 08/2011
1	Skin Ulcer 10/2010
1	Telangiectasis (Telangiectasia) 10/2009
1	Calcinosis 10/2009
1	Contracture 10/2004
1	Collagen Diseases (Collagen Disease) 10/2004
1	Connective Tissue Diseases (Connective Tissue Disease) 08/2004
1	Pulmonary Hypertension 02/2003
1	Arthritis (Polyarthritis) 01/2003
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2001

Drug/Important Bio-Agent (IBA)

3	CollagenIBA 11/2014 - 02/2006
3	Rheumatoid FactorIBA 07/2005 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 05/2016
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2017 - 04/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017 - 04/2010
2	Immunoglobulin A (IgA)IBA 01/2013 - 10/2004
2	MicroRNAs (MicroRNA)IBA 01/2012 - 11/2011
2	Carbon MonoxideIBA 10/2009 - 03/2006
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2007 - 06/2005
2	Matrix Metalloproteinase 13IBA 07/2006 - 03/2006
2	Immunoglobulin M (IgM)IBA 07/2005 - 10/2004
2	agalactosyl IGGIBA 04/2005 - 10/2004
2	AntibodiesIBA 04/2005 - 10/2004
2	Tissue Inhibitor of MetalloproteinasesIBA 08/2004 - 07/2002
2	Tissue Inhibitor of Metalloproteinase-1IBA 08/2004 - 07/2002
2	CD40 Ligand (CD40L)IBA 02/2003 - 02/2003
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Keratin-19 (Keratin 19)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Carcinoembryonic AntigenIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2017
1	STA 9090IBA 08/2017
1	Taxoids (Taxanes)IBA 08/2017
1	Small Interfering RNA (siRNA)IBA 08/2017
1	Molecular Chaperones (Chaperone, Molecular)IBA 08/2017
1	InterferonsIBA 05/2016
1	MucinsIBA 05/2016
1	Phosphotransferases (Kinase)IBA 12/2013
1	Protein Isoforms (Isoforms)IBA 12/2013
1	JNK Mitogen-Activated Protein KinasesIBA 12/2013
1	ErbB Receptors (EGF Receptor)IBA 03/2013
1	Infliximab (Remicade)FDA Link 01/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2012
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2012
1	CyclinsIBA 11/2011
1	Trastuzumab (Herceptin)FDA Link 08/2011
1	Vascular Endothelial Growth Factor DIBA 10/2010
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 10/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2010
1	Peptides (Polypeptides)IBA 07/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2006
1	Superoxide DismutaseIBA 07/2005
1	Anti-Idiotypic AntibodiesIBA 10/2004
1	Immunoglobulin G (IgG)IBA 10/2004
1	Penicillamine (Cuprimine)FDA Link 10/2003
1	plasmin-plasmin inhibitor complexIBA 02/2003
1	ImmunosorbentsIBA 02/2003
1	EnzymesIBA 02/2003
1	C-Reactive ProteinIBA 01/2003
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2002
1	AntigensIBA 10/2002
1	Tissue Inhibitor of Metalloproteinase-2IBA 07/2002
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 11/2001

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 08/2017
1	Phototherapy (Light Therapy) 03/2012